Senior Partner, Hector MacKay-Dunn, presented the Company of the Year Award to Aurinia Pharmaceuticals Inc. at the 20th Annual LifeSciences BC Awards Dinner held on April 19, 2018.

This award recognizes the company of the year which demonstrated strong overall performance and accomplishments in the past year. Aurinia is a clinical stage biopharmaceutical company focused on developing and commercialising therapies in disease areas of high unmet medical need. Currently, their research focus is on its long-term commitment to advancing treatments for lupus and lupus nephritis.

“Farris is delighted that Aurinia has been recognized as the leading life sciences company of the year” said Mr. MacKay-Dunn. We extend our very best wishes to the entire Aurinia team and stakeholders for its outstanding accomplishments to date and wish them a successful 2018 in its work toward advancing treatments for lupus and lupus nephritis.